Results of our study indicated that MNK2 alternative splicing is essential for the tumor suppressive role of RALYL so that RALYL may inhibit CRC through regulating MNK2 alternative splicing by increasing MNK2a and decreasing MNK2b. The gene discussed is RALYL; the disease is neoplasm.